A venture capital firm headquartered in Melbourne, Australia is looking to make makes equity investments from $3M-5M. The firm anticipates about 6 new investments this year and looks to invest invests globally.
The firm will invest in companies across the life science space, including therapeutics, diagnostics and medical technology. The group does not invest in service providers. The firm considers all subsectors and indications, including orphan indications. The group will consider technology either in or prepared for human clinical trials and is open to all classes of devices. The firm seeks investments in novel technology and is not looking to gain share of an existing market.
The firm is open to co-investments and considers public or private companies. The group will only consider companies with granted patents or a clear patent strategy. Companies of interest must have a remote connection with Australia or the Pacific Region. This may include a facility or a partner located in the region.
If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com
Next Phase Newsletter 